Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sernova Corp (SVA.TO)

Sernova Corp (SVA.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 79,705
  • Shares Outstanding, K 325,325
  • Annual Sales, $ 0 K
  • Annual Income, $ -38,998 K
  • 60-Month Beta 1.20
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade SVA.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.13
  • Most Recent Earnings $-0.02 on 09/16/24
  • Next Earnings Date 09/18/24
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 10/31/24
See More
  • Average Estimate -0.03
  • Number of Estimates 2
  • High Estimate -0.02
  • Low Estimate -0.03
  • Prior Year -0.04
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2300 +4.35%
on 08/28/24
0.3350 -28.36%
on 09/06/24
unch (unch)
since 08/26/24
3-Month
0.2000 +20.00%
on 08/19/24
0.3500 -31.43%
on 07/03/24
-0.0950 (-28.36%)
since 06/26/24
52-Week
0.2000 +20.00%
on 08/19/24
0.8300 -71.08%
on 09/29/23
-0.5100 (-68.00%)
since 09/26/23

Most Recent Stories

More News
Stocks in play: Sernova Corp.

Announces today that David Paterson Ph.D. will join Sernova’s Board of Directors effective immediately. ...

SVA.TO : 0.2400 (-2.04%)
Stocks in play: Sernova Corp.

Announced the presentation of new positive interim data from the ongoing Phase I/II clinical trial evaluating ...

SVA.TO : 0.2400 (-2.04%)
Stocks in play: Sernova Corp.

Has closed its non-brokered, private placement in the amount over $5.2 million, which includes over-subscriptions ...

SVA.TO : 0.2400 (-2.04%)
Stocks in play: Sernova Corp.

Today announced a short oral presentation at the upcoming European Association for the Study of Diabetes ...

SVA.TO : 0.2400 (-2.04%)
Stocks in play: Sernova Corp.

Announces developments in its Phase I/II clinical trial investigating a novel treatment for Type 1 Diabetes ...

SVA.TO : 0.2400 (-2.04%)
Sernova Announces Marketed Public Offering of Units

/CNW/ - Sernova Corp. ("Sernova" or the "Company") (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH) is pleased to announce that it has filed a preliminary short form...

RJF : 122.52 (-2.06%)
SEOVF : 0.1800 (+0.45%)
SVA.TO : 0.2400 (-2.04%)
U.S. Jobs Reports Due Next Week

Monday U.S. Featured Earnings Nucor Corporation (NYSE:NUE) (Q4) EPS of $2.83, compared ...

FLOW.TO : 0.1700 (unch)
SVA.TO : 0.2400 (-2.04%)
CLS.TO : 70.16 (+2.56%)
Stocks in play: Sernova Corp.

Announced the U.S. Food and Drug Administration (FDA) has granted both Orphan Drug Designation (ODD) ...

SVA.TO : 0.2400 (-2.04%)
Stocks in play: Sernova Corp.

Announced an update on its conformal coating immune protection technology program, that is used in combination ...

SVA.TO : 0.2400 (-2.04%)
Stocks in play: Sernova Corp.

Today presented interim positive results from its ongoing Phase 1/2 clinical trial investigating islet ...

SVA.TO : 0.2400 (-2.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is is a scalable,...

See More

Key Turning Points

3rd Resistance Point 0.2567
2nd Resistance Point 0.2533
1st Resistance Point 0.2467
Last Price 0.2400
1st Support Level 0.2367
2nd Support Level 0.2333
3rd Support Level 0.2267

See More

52-Week High 0.8300
Fibonacci 61.8% 0.5893
Fibonacci 50% 0.5150
Fibonacci 38.2% 0.4407
Last Price 0.2400
52-Week Low 0.2000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar